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Mitochondrial dysfunction (MD) has been identified in lymphocytes, fibroblasts and
brain samples from adults carrying a 55–200 CGG expansion in the fragile X mental
retardation 1 (FMR1) gene (premutation; PM); however, limited data are available on
the bioenergetics of pediatric carriers. Here we discuss a case report of three PM
carriers: two monozygotic twins (aged 8 years) harboring an FMR1 allele with 150–180
CGG repeats, with no cognitive or intellectual issues but diagnosed with depression,
mood instability and ADHD, and their mother (asymptomatic carrier with 78 CGG
repeats). Fibroblasts and lymphocytes from the twins presented a generalized OXPHOS
deficit, altered mitochondrial network, accumulation of depolarized mitochondria, and
increased mitochondrial ROS production, outcomes distinct and more severe than
the mother’s ones, suggesting the involvement of modulatory effects mediated by
CGG expansion, X-activation ratio, sex hormones and epigenetic factors (chronic
inflammation, consequence of Lyme disease). The degree of the severity of MD
appeared to segregate with the morbidity of the phenotype. The mitochondrial ROS-
mediated HIF-1α stabilization was identified as a key player at contributing to the MD,
pointing it as a novel target for future therapeutical intervention.
Keywords: bioenergetics, FXTAS, mitochondrial dysfunction, oxidative stress, premutation
INTRODUCTION
Premutation (PM) carriers are individuals with a modestly expanded CGG nucleotide repeat (55–
200) in the 5′-UTR of the fragile X mental retardation gene, FMR1 (Hagerman and Hagerman,
2013). Adult carriers often have a subtle phenotypic profile, worsening as they age into poor
performance on executive and visuospatial tasks, increased difficulties with math and increased
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; ASD, autism spectrum disorders; FMR1, fragile X mental
retardation 1; FMRP, fragile X mental retardation protein; FXS, fragile X syndrome; FXPOI, fragile X-associated primary
ovarian insufficiency; FXTAS, fragile X-associated tremor and ataxia syndrome; HIF-1α, hypoxia-inducible factor 1-
alpha; L/P, lactate-to-pyruvate ratio; MD, mitochondrial dysfunction; MZ, monozygotic; NC, non-carriers; OXPHOS,
oxidative phosphorylation; PM, premutation; qRT-PCR, quantitative-real time PCR; ROS, reactive oxygen species; UPRmt,
mitochondrial unfolded protein response; XAR, X-chromosome activation ratio.
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symptoms of anxiety. The PM in adults increases the risk
for developing the neurodegenerative disease known as FXTAS
(Berry-Kravis et al., 2007) and, in women only, FXPOI (Sherman,
2000).
Pediatric PM carriers (≤18 years old) are often diagnosed
with ADHD, anxiety and other psychopathologies (Bailey et al.,
2008), albeit at a lower incidence than in individuals affected with
FXS, the most common inherited form of intellectual disability,
carrying a full FMR1 mutation (>200 CGG repeats). Indeed, the
incidence of ASD in PM carriers is ∼15% (Farzin et al., 2006)
whereas in FXS is 60% (Hagerman et al., 2010). In the first
national parent-report survey of families with FXS performed
with a relatively large sample size (Bailey et al., 2008) parents
reported higher frequencies of developmental delay (boys and
girls), attention problems (boys and girls), aggressiveness (boys),
autism (boys), seizures (boys), anxiety (boys and girls) and
depression (girls) in pediatric carriers. Two other studies found
developmental differences in infants carrying the PM compared
with NC controls, differences that may be viewed as early markers
of anxiety, social deficits, or other developmental challenges later
in life (Wheeler et al., 2016).
Bioenergetic deficits, or mitochondrial dysfunction (MD),
with increased oxidative stress biomarkers have been observed in
post-mortem brain samples (Ross-Inta et al., 2010), lymphocytes
(Napoli et al., 2016a), fibroblasts (Ross-Inta et al., 2010; Napoli
et al., 2016b), and plasma (Giulivi et al., 2016) from young and
adult PM carriers. These deficits correlated with both CGG repeat
expansion and severity of the phenotype (Ross-Inta et al., 2010;
Napoli et al., 2011). Given the critical role of mitochondria in
energy and neurotransmitter metabolism (Laughlin et al., 1998),
MD may contribute to the adult PM phenotype, but whether
these metabolic changes appear at early stages of life is unknown.
In this study, we present a case of MZ twins identified as PM
carriers (males, aged 8 years), recruited through the Fragile X
Treatment and Research Center (MIND Institute at UC Davis).
They exhibited relatively long and unstable CGG repeat (upper
PM range) in the 5′UTR of the FMR1 gene in both fibroblasts
and lymphocytes and were diagnosed with severe psychological
and emotional problems but no cognitive deficits. MZ twins have
identical genotypes, and any putative differences in outcomes are
theoretically due to environmental factors. Thus, the aim of this
study was to investigate the impact of genetic versus non-genetic
factors by evaluating the bioenergetics of lymphocytes and
primary dermal fibroblasts from young MZ PM carriers and
their mother (a relatively asymptomatic PM carrier) compared
to age-matched NC, and to determine whether the putative MD
segregated with either specific symptoms and/or phenotypic
severity.
MATERIALS AND METHODS
Chemicals and Biochemicals
EDTA, EGTA, KH2PO4, sodium succinate, digitonin, rotenone,
antimycin A, oligomycin, malonate, ascorbic acid, N,N,N′,N′-
tetramethyl-p-phenylenediamine, KCN and HEPES were
purchased from Sigma (St Louis, MO, United States). Tris–HCl,
glycine, sodium chloride and KCl were purchased from Fisher
(Pittsburg, PA, United States). Bovine serum albumin (fatty acid
free) was obtained from MP Biomedicals. All reagents were of
analytical grade or higher.
Isolation of Lymphocytes From Blood
Samples and Fibroblasts Growing
Conditions
Blood samples were obtained from both twins at three different
times (August 2013, January 2014, and March 2016). Blood
samples from both parents were collected only at the latest time
point. All blood samples (including the ones obtained from adult
donors, average age ± SEM = 37.4 ± 3.5) were collected by
venipuncture with informed consent at the MIND Institute and
approved by the institutional review board ethics committee
at UC Davis Medical Center. Blood (5–8 ml) was collected in
Vacutainer CPT tubes (Applied Biosystems, Foster City, CA,
United States) and lymphocytes were isolated as previously
described (Napoli et al., 2016a).
Skin biopsies from the twins and their mother were obtained
in January 2014. To minimize confounding factors, our study was
focused in several ways: (i) We concentrated on bioenergetics
deficits that were conserved in primary (lymphocytes) and
primary culture of skin fibroblasts. (ii) All fibroblasts were studied
at the same early stage of population doubling (passages 6–
10), where significant telomere shortening and corresponding
features of replicative senescence could be excluded. (iii) The
study was restricted to dermal fibroblasts derived from age-
and sex- matched healthy adult donors for the mother and the
twins, thus excluding age or gender influence on skin aging.
(iv) Skin fibroblasts were isolated from the same skin area
(punch biopsy on left upper back) to minimize variances due
to body site or different exposure to the external milieu. All
fibroblasts from carriers were obtained from Dr. P. Hagerman.
Age- and sex-matched fibroblast controls were obtained from the
Coriell Biorepository (Camden, NJ, United States). Fibroblasts
were grown in high glucose Minimum Essential Medium
supplemented with 15% FBS, 2 mM glutamine, 1 mM sodium
pyruvate, as previously described (Napoli et al., 2011).
Isolation of Genomic DNA, CGG Sizing
and qRT-PCR
Genomic DNA was isolated from lymphocytes using Gentra
Puregene Blood Kit (Qiagen, Valencia, CA, United States). CGG
sizing was obtained using a combination of PCR (AmplideX
PCR/CE FMR1 Kit; Asuragen Inc. Austin, TX) and Southern
blot analysis (Tassone et al., 2008) and measured as previously
described (Filipovic-Sadic et al., 2010). Methylation status of
the FMR1 promoter and specifically the XAR in the mother
and the percent of methylation in the two twins was measured
on Southern Blot using the Alpha Innotech FluorChem 8800
Image (Tassone et al., 1999). Total RNA was obtained from whole
blood collected in Tempus tubes using manufacture instructions
(Applied Biosystems, Foster City, CA, United States) and qRT-
PCR was performed as detailed in Tassone et al. (2000).
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Evaluation of Mitochondrial Mass,
Morphology and Distribution by Confocal
Microscopy in Fibroblasts
Cells (passages 7–10, 1 × 105) were seeded on sterile coverslips,
grown over night at 37◦C and then incubated for 30 min at
37◦C with 0.5 µM MitoTracker Red CMXRos (MolecularProbes
Inc., Eugene, OR, United States) diluted in growth media (Napoli
et al., 2016b). More details are provided under Supplementary
Information. For mitochondrial morphology quantification,
images were further analyzed with two macro tools designed for
ImageJ (Fiji) (Dagda et al., 2009; Valente et al., 2017) to allow
the quantification of mitochondrial mass, morphological features
and network integrity. Mitochondrial cellular distribution was
evaluated using the Fiji surface plot feature, followed by plot
profile analysis.
Mitochondrial Bioenergetics
Mitochondria-dependent oxygen consumption was evaluated in
either fibroblasts or freshly isolated lymphocytes permeabilized
with digitonin as previously described (Giulivi et al., 2010).
Methodological details are reported under Supplementary
Information. Citrate synthase activities were evaluated
spectrophotometrically as described elsewhere (Napoli et al.,
2011) using the equivalent of 2.0–5.0× 104 cells.
Mitochondrial ROS Production
Cells (passages 7–10, 1 × 105) were seeded on sterile cover
slips, grown over night at 37◦C and subsequently incubated for
10 min at 37◦C with 5 µM MitoSOX (ThermoFisher Scientific),
prepared as per manufacturer’s instruction and diluted in growth
media, washed thoroughly and subsequently counterstained with
1 µg/ml 4′,6 diamidino-2-phenylindole (DAPI) and mounted on
glass slides with ProLong Gold anti-fade mounting medium for
fixed cells. Images (10–15 for each cell line) were obtained with an
Olympus FV1000 laser scanning confocal microscope (excitation
and emission wavelengths 594 and 660 nm) at 60×magnification.
Analysis of fluorescence intensity was carried out with Fiji and
normalized by cell area.
Gene Expression in Fibroblasts From
Premutation Carriers and Age-Matched
Controls
RNA was isolated from fresh fibroblast cells containing
2 × 106 cells using the RNEasy Plus Mini Kit from Qiagen
(cat. no. 74134) following the manufacturer’s instructions.
cDNA was synthesized using Qiagen’s Quantitect RT kit
(cat no. 205311) following manufacturers recommendations.
RNA and cDNA concentrations were determined using
the Tecan Infinite M200 Nanoquant plate reader (Tecan,
Austria). All primers/probe mix were from Life Technologies
(Grand Island, NY, United States). Sequences of commercial
primers and probes are proprietary. cDNA was diluted to
40 ng/µl and served as stock template for qRT-PCR. See
Supplementary Information and Supplementary Figure 1 for
more details.
Evaluation of mtDNA Copy Number and
Deletions
These assays were performed on genomic DNA extracted from
lymphocytes and fibroblasts by using qRT-PCR and essentially as
described in Giulivi et al. (2010). Other details are included under
the Supplementary Information.
Western Blotting
Fibroblasts from twins, their mother and relative controls were
lysed in RIPA buffer and assessed by Western blots as previously
described (Napoli et al., 2013). Membranes were visualized with
the use of the Odyssey Infrared Imaging System (LI-COR).
Densitometry analysis was carried out with ImageJ. The complete
list of antibodies used with relative dilutions and commercial
source is reported under Supplementary Table 1. Additional
methodological details are under Supplementary Methods.
Statistical Analysis
Data from twins’ and their mother are expressed as mean ± SD
and compared to the 95% CI built with values from age- and sex-
matched controls. The number of control samples (fibroblasts
and lymphocytes) used to calculate the 95% CI for each outcome
are reported in each of the individual tables and figures for both
children and adults.
RESULTS
Clinical Description of Carriers
Presented in This Study
Both twins presented normal or above IQ with no intellectual
or cognitive issues. However, both twins were diagnosed
with depression, mood instability and ADHD. Twin 2 only
was diagnosed with bipolar disorder, manic behavior, motor
coordination problems, poor stamina, and chronic fatigue, the
latter probably developed after an episode of Lyme disease
(Table 1 and Supplementary Information). The mother was
a 38-year PM carrier (CGG repeats allele sizes: 43, 78), with
no psychiatric or medical problems associated with the PM,
but at age 36, she met criteria for FXPOI, reported some word
retrieval problems and monthly migraines (more details under
Supplementary Information).
Description of FMR1-Related Molecular
Outcomes in Fibroblasts and
Lymphocytes
Lymphocytes from the twins harbored FMR1 alleles in the upper
PM range of approximately the same size (157–180 CGG repeats
for twin 1 and 150–180 for twin 2). Although a full mutation allele
was not observed in the twins, we cannot exclude its presence in
a very small percent of cells that was under the detection limit. In
fibroblasts, the CGG repeats were approximately the same size as
in the lymphocytes, as observed by Southern blots (Figure 1A).
A broader range of CGG repeat size alleles was observed in
both cell types from both twins, indicating the presence of
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TABLE 1 | Clinical and medication history of Pre twins analyzed in this study.
Twin 1 Twin 2
Developmental milestones (months)
Sitting independently (ref. 3–8 m) 6 6
Crawling (ref. 5–13 m) 10 9
Walking (ref. 8–18 m) 15 14
First words (ref. 12–18 m) 24 24
First sentences (ref. 24 m) 42 42
Characteristics at the time of examination
Blood pressure [mmHg [percentile]
(National High Blood Pressure Education
Program Working Group on High Blood
Pressure in Children and Adolescents,
2004)]
88/56 [<50th] 93/50 [50th]
Head circumference [cm [percentile] (Rollins
et al., 2010)]
52.5 [50th] 52.5 [50th]
Height [cm [percentile] (U.S. Department of
Health and Human Services, 2008]
118.1 [15th ] 119.9 [19.6th]
Weight [kg [percentile] (U.S. Department of
Health and Human Services, 2008]
18.96 [3.8th] 22.5 [34th]
Body Mass Index [percentile] (Kuczmarski
et al., 2002)
13.6 [3rd] 15.6 [47th]
Full scale IQ (Wechsler, 2003) 123 [94th] 99 [47th]
Medications
Lisdexamfetamine (VyvanseTM) (past) Yes No
Risperidone (RisperdalTM) (past) No Yes (0.5 mg)
Methylphenidate (ConcertaTM) (current) Yes Yes (18 mg)
Guanfacine (TenexTM) (current) Yes Yes
Sertraline (ZoloftTM) (current) Yes (50 mg) Yes (25 mg)
Melatonin (current) Yes No
N-acetyl-L-cysteine (current) Yes (250 mg) Yes (300 mg)
Vitamin B complex (current) Yes Yes
Omega 3s (current) Yes Yes
Aripiprazole (AbilifyTM) (current) Yes Yes
Behavioral traits∗
• Major depressive episode (age 5) in partial remission
• Agoraphobia without history of panic disorder (age 5–7)
in partial remission, specific phobia (animal type).
• ADHD combined type
• Eating disorder NOS in full remission.
• Sub-threshold evidence of enuresis (not full clinical
criteria)
• Depressive disorder NOS (age 7) in partial remission
• Bipolar disorder NOS
• ADHD combined type
• Evidence of mania current and past
• Motor coordination problems
• Poor stamina after Lyme disease
Medical history
• Recurrent ear infections
• Inguinal hernia repair (age 3.5)
• Reactive airway disease intermittently treated with a
bronchodilator inhaler and occasional use of oral steroids
and more frequent use of nasal steroids
• Recurrent ear infections
• Umbilical hernia resolved in the first few years of life and
recent repair of a right inguinal hernia
• Reactive airway disease and seasonal allergies
• Lyme disease (age 6) with erythema under his arms
NOS, Not Otherwise Specified; ADHD, Attention Deficit Hyperactivity Disorder; ∗diagnosis criteria for behavioral traits = KSADS or the Kiddie-schedule for affective
disorders and schizophrenia. Developmental milestones normative values as well as other normative values were obtained from (National Research Council and Institute
of Medicine, 2000; Wechsler, 2003; WHO Multicentre Growth Reference Study Group, 2006).
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FIGURE 1 | Length of the CGG repeat and methylation level in lymphocytes and fibroblasts from twins. (A) Representative Southern blot of CGG repeats carried out
with lymphocytes (LY) and fibroblasts (FB) from twin 1 (T1) and twin 2 (T2). AG (lane 2) and GM (lane 7) are negative (non-carrier female) and positive (full mutation
controls), respectively. Normal, unmethylated band (2.8 kbp) and normal, methylated band (5.2 kbp) are indicated on the left. Size marker (labeled as 1 kbp) is shown
in Lane 1. (B) Capillary electrophoresis of PCR products amplified from genomic DNA isolated from blood and correspondent fibroblasts from the two twins
demonstrates the presence of allele instability and somatic mosaicism in both blood and fibroblasts and in both subjects, as visualized by a series of peaks. The
x-axis indicates the number of base pairs and the y-axis indicates relative fluorescence intensity. (C) Representative Western blot showing FMRP protein levels in
fibroblasts from twins, their mother and correspondent age- and sex-matched controls (n = 4 for each sex- and age-matched group). Tubulin was used as loading
control. (D) Densitometry values of FMRP normalized by tubulin intensity. 95% CI are shown in brackets. Data for the trio are shown as mean ± SD (as means of
showing intra-experiment variability). Bolded are values lower than the 95% CI lowest limit.
extreme somatic instability and inter- and intra-tissue somatic
mosaicism (Figure 1B). The FMR1 mRNA expression levels
in lymphocytes were ∼6-fold higher than age-matched control
values, whereas the percentage of FMR1 promoter methylation
was approximately 3 and 2% in lymphocytes and 8 and 3% in
fibroblast cell lines in twin 1 and in twin 2, respectively (Table 2),
with undetectable promoter methylation in age-matched controls
(Tassone et al., 2000). The mother carried FMR1 alleles of
identical CGG length (43, 78 CGG repeat) in both peripheral
blood and fibroblasts, with an X-activation ratio (XAR; defined
as the proportion of cells that carry the normal FMR1 allele
on the active X chromosome) of 0.15 and 0.17 respectively.
FMR1 expression levels were ∼2-fold higher than in control
lymphocytes (Table 2).
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TABLE 2 | Triplet expansion, gene expression and methylation in FMR1 gene in samples from premutation carriers∗.
Outcome Tissue Controls Twin 1 Twin 2 Mother
CGG repeats in each allele Lymphocytes∗ 28 ± 2 (a) Premutation smear∗∗ Premutation smear∗∗∗ 43, 78
Fibroblasts 30 ± 1 (b) Premutation smear∗∗ Premutation smear∗∗∗ 43, 78
FMR1 gene expression (fold change)¶ Lymphocytes∗ 1 (a) 5.3 4.2 2.3
Fibroblasts 1 (c) 1.3 −1.3 1.1
Methylation on FMR1 promoter Lymphocytes∗ <1% (d) 3% <2% XAR = 0.15
Q. 0. Fibroblasts NA 8% 3% XAR = 0.17
(a) Control values (n = 12) have been published in Napoli et al. (2016b). (b)Control values (n = 12) have been published in Napoli et al. (2016a). (c) Control values
were obtained from either male children (n = 5) with an average age of 8.8 ± 0.8 year (mean ± SEM) or adult females (n = 5) with an average age of 39.8 ± 2.5 year
(mean ± SEM). (d) Taken from Tassone et al. (2000). ¶ Fold change referred to age- and sex-matched controls. ∗Analyses were performed in August 2013. ∗∗CGG = series
of alleles throughout the premutation range with main alleles at 157 and 180 (see Figure 1B). ∗∗∗CGG = series of alleles throughout the premutation range with main
alleles at 138 and 162 CGG (see Figure 1B). NA, not available. XAR, X-activation ratio.
In fibroblasts, the FMR1 mRNA expression levels in the twins
and their mother were not different from sex- and age-matched
NC controls. The FMRP expression, as evaluated by Western
blots, resulted in a main band at∼80 kD whose levels were below
the 95% CI. The same pattern was observed for the mother, albeit
at a lower extent (Figure 1C).
FMR1 Premutation Alters Mitochondrial
Function and UPRmt
Average mitochondrial outcomes from the twins’ lymphocytes
assessed at 3 different time points (Supplementary Figure 2)
were compared to age- and sex-matched NC (Table 3). The
selection of controls was based on the fact that FMR1 is
an X-linked gene and OXPHOS and other mitochondrial
enzymes change with age (Rooyackers et al., 1996; Capkova
et al., 2002). The most relevant changes in mitochondrial
outcomes for both twins were the following: (a) decreased
mitochondrial capacity to produce ATP fueled by both NAD-
and FAD-linked substrates; (b) lower mitochondrial mass
(citrate synthase activity), deficits in Complex IV and lower
mtDNA copy number per cell, and (c) increased ROS/proton
leak. The deficits in ATP production were (in most cases)
proportional to those of mitochondrial mass (Table 3) indicating
imbalances between mitochondria biogenesis (including mtDNA
replication) and clearance, more than deficits at specific
Complexes or segments of the electron transport chain.
When mitochondrial outcomes tested in lymphocytes were
compared between the twins, the bioenergetics from twin 2
resulted to be 39% lower than those of twin 1 (mitochondrial
outcomes from twin 2 = 0.61 × mitochondrial outcomes
from twin 1 + 0.16; R2 = 0.462; p < 0.0001; Supplementary
Figure 2).
When the outcomes from the twins were compared to
their parents’ lymphocytes—obtained during the last visit—
the mother’s outcomes were similar to those from the twins
(i.e., decreased ATP production mainly attributed to lower
mitochondrial mass, lower Complex IV activity, and decreased
coupling with increased ROS/proton leak; Table 3), albeit to
a lower extent. The father’s lymphocytes showed decreased
ATP production mainly with NAD-linked substrates, also
proportional to the decrease in mitochondrial mass (citrate
synthase activity) compared to age-matched controls (Table 3).
All other outcomes in the father’s lymphocytes were within
control values (Table 3).
Milder changes in the bioenergetics of fibroblasts of the
carriers were noted compared to those of lymphocytes.
Fibroblasts from both twins showed a modest impairment in
ATP production fueled by NAD-linked substrates, increased
uncoupling, higher ROS/proton leak and lower Complex IV
activity along with increased mtDNA deletions in twin 2’s
cells (Table 4). It is possible that the increased ROS/proton
leak observed in both twins results in ROS-mediated damage
to Complex I, leading to lower NAD-linked ATP production
(Table 4). Differently from lymphocytes, when outcomes from
fibroblasts (Table 4) were compared between brothers, both
seemed equally affected (mitochondrial outcomes from twin
2 = 1.12 × mitochondrial outcomes from twin 1− 0.08;
r2 = 0.908; p< 0.0001; Supplementary Figure 2).
Fibroblasts from the mother showed similar decreases in
both FAD-linked oxygen uptake and citrate synthase activity but
compensated by an increased ATP production at the level of
Complex I (i.e., NAD-linked oxygen uptake normalized by citrate
synthase activity). A marginal increase in ROS/proton leak and
the lack of changes in coupling are indicative of a better clearance
of damaged mitochondria. The higher mtDNA copy number
per cell indicates an underlying increased oxidative stress which
triggers an increased replication of naive (undamaged) mtDNA
template (Table 4).
When mitochondrial outcomes from lymphocytes were
correlated to those obtained with their fibroblasts’, several
outcomes, especially from twin 2, fell outside the 95% CI (5 vs.
3 for twin 1; Figure 2). In the mother, values for most outcomes
from both cell types were within the 95% CI (Figure 2). In
agreement with the substantial residual bioenergetics’ capacity
of fibroblasts relative to other systems [even in cases of
pathogenic mtDNA mutations (Thorburn and Smeitink, 2001)],
mitochondrial parameters in lymphocytes from NC were 24–
30% of fibroblasts from NC, indicative of a different cell-specific
OXPHOS capacity.
Notably, the stoichiometric balance between components of
OXPHOS complexes was disrupted in the carriers’ fibroblasts.
In the case of the twins, these altered ratios seemed ascribed
to lower Complex IV activity, whereas in the case of the
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TABLE 3 | Mitochondrial outcomes in lymphocytes from premutation twins and their parents.
Outcome Children
controls¶
(n = 10)
Twin 1 Twin 2 Adult controls
(n = 7)
Mother Father
ATP-driven oxygen uptake Substrate
Malate-glutamate∗ 1.6 ± 0.1
[1.4–1.8]
0.9 ± 0.5 0.5 ± 0.1 1.2 ± 0.2
[0.7–1.7]
0.35 ± 0.04 0.3 ± 0.2
Succinate∗ 1.6 ± 0.2
[1.1–2.1]
0.6 ± 0.2 0.4 ± 0.1 1.4 ± 0.2
[0.9–1.9]
0.35 ± 0.03 0.74 ± 0.07
Markers of mitochondrial inner membrane and matrix
Complex IV activity ∗ 2.1 ± 0.4
[1.2–3.0]
0.7 ± 0.3 0.8 ± 0.3 2.2 ± 0.4
[1.2–3.2]
0.8 ± 0.4 1.4 ± 0.6
Citrate synthase activity∗ 15 ± 2
[10–20]
7.3 ± 1.4 4.8 ± 0.8 7.6 ± 0.4
[6.6–8.6]
1.45 ± 0.09 1.7 ± 0.3
CCO/CS 0.14 ± 0.02
[0.09-0.19]
0.10 ± 0.05 0.17 ± 0.06 0.29 ± 0.06
[0.14–0.44]
0.6 ± 0.3 0.9 ± 0.4
Others
RCRu 3.2 ± 0.3
[2.5–3.9]
3.0 ± 2.0 4.8 ± 3.0 8 ± 2
[3–13]
1.1 ± 0.2 6.9 ± 0.7
SRC (%) 239 ± 44
[139–339]
145 ± 26 275 ± 249 309 ± 48
[191–426]
350 ± 40 208 ± 20
ROS/Proton leak (%) 47 ± 5
[36–58]
60 ± 24 70 ± 15 37 ± 7
[20–54]
325 ± 35 30 ± 3
mtDNA copy number per cell 1692 ± 242±
[1089–2293]
579 ± 49 508 ± 50 ND ND ND
mtDNA deletions 1.00 ± 0.05±
[0.87–1.13]
0.89 ± 0.04 0.85 ± 0.14 ND ND ND
∗Expressed as [nmol × (min × 106 cells)−1]. RCRu, Respiratory Control Ratio under uncoupling conditions; SRC, Spare Respiratory Capacity. SRC expressed as the
percentage of FCCP-induced oxygen uptake rate over the baseline one. ROS/proton leak as the percentage of oligomycin-induced oxygen uptake rate over the baseline
one. ¶ Controls values for OXPHOS and enzymatic activities were taken from (Giulivi et al., 2010) and are consistent with the historic pediatric values obtained in our
laboratory. ±Control values of mtDNA copy number and deletions were obtained from control male children (n = 6) with an average age of 9.6 ± 0.7 year. Data are
reported as mean ± SEM for controls whereas twins’ data are expressed as mean ± SD for premutation carriers (average values obtained at three different dates, i.e.,
08/15/2013, 01/27/2014 and 03/24/2016). Bolded values are below the 95% CI limit, except ROS/proton leak which is above. Bold and underlined, values ≤ 30% of
control average. ND = not determined due to the limited amount of biological material available.
mother to lower Complex II activity (within the succinate-
dependent oxygen uptake; Table 4). Altered ratios of OXPHOS
Complexes triggers the UPRmt which entails the expression
of mitochondrial chaperones to assemble subunits into multi-
subunit functional complexes (Jovaisaite et al., 2014). Consistent
with these findings, the majority (67%) of mitochondrial proteins,
representative of four mitochondrial sub-compartments (outer
membrane, intermembrane space, inner membrane and matrix),
were higher in twin 2’s cells; conversely, 44% and 22%
showed higher abundance in twin 1’s and mother’s cells,
respectively (Supplementary Figure 3). These results suggested
an accumulation of misfolded, inactive mitochondrial proteins in
twin 2’s cells, likely through a disrupted UPRmt, and consistent
with the accumulation of damaged mtDNA (Table 4).
To test the status of UPRmt, we evaluated the gene expression
of three key genes (i) the leucine-rich pentatricopeptide repeat
motif-containing protein [LRPPRC; also known as LRP130] also
involved in autophagy/mitophagy and Complex IV activity; (ii)
the mitochondrial chaperone HSP70 and (iii) the mitochondrial
protease CLPP. These experiments were complemented by
assessing the expression of selected genes involved in mtDNA
maintenance, OXPHOS subunits and assembly factors, as well
as the mitochondrial disulfide relay system. The gene expression
of LRPRRC and HSP70 was consistent with the activation of
UPRmt in twin 2’s cells, whereas no changes (twin 1’s cells) or
the opposite trend was observed in the mother’s cells. Analysis
of the remaining 27 genes (Figure 3) showed no changes in
the expression of the majority of genes in twin 2 (58% within
NC values), whereas in twin 1 and his mother, the majority was
up-regulated (45% and 69%, respectively).
Taken together, the gene expression of LRPRRC and HSP70,
the accumulation of mitochondrial proteins (Supplementary
Figure 3) and damaged mtDNA (Table 4) were consistent
with a defective activation of the UPRmt avoiding mitophagy
in an attempt to preserve some OXPHOS activity (Lin et al.,
2016). In the mother’s and twin’s 1 cells, while no activation
of UPRmt was observed, the up-regulation of most genes
tested suggested an attempt to balance mitochondrial biogenesis,
mitochondrial proteostasis and mitophagy (Jin and Youle,
2013).
Disrupted Mitochondria Morphology,
Mass and Network in Fibroblasts From
PM Carriers
To test the steady-state of dysfunctional mitochondria, fibroblasts
were stained with MitoTracker Red CMXRos (dye that requires
polarized mitochondria for its accumulation) and visualized
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TABLE 4 | Mitochondrial outcomes in cultured fibroblasts from premutation twins and their mother.
Outcome Children
controls (n = 5)
Twin 1 Twin 2 Adult controls
(n = 5)
Mother
ATP-driven oxygen uptake
Substrate
Malate-glutamate∗ 4.6 ± 0.3
[3.8–5.4]
3.21 ± 0.01 3.54 ± 0.06 3.9 ± 0.8
[1.7–6.1]
2.2 ± 0.1
Succinate∗ 4.2 ± 0.9
[1.9–6.5]
3.61 ± 0.06 3.8 ± 0.5 3.0 ± 0.4
[1.9–4.1]
1.2 ± 0.1
Markers of mitochondrial inner membrane and matrix
Complex IV activity∗ 3.2 ± 0.4
[2.1–4.2]
1.7 ± 0.4 1.8 ± 0.3 3.1 ± 0.4
[2.0–4.2]
2.6 ± 0.2
Citrate synthase activity∗ 5 ± 1
[2.4–7.6]
4.7 ± 0.3 5.2 ± 0.3 5.0 ± 0.9
[2.5–7.5]
1.9 ± 0.9
CCO/CS 0.6 ± 0.1
[0.34–0.86]
0.36 ± 0.09 0.38 ± 0.07 0.67 ± 0.08
[0.45–0.89]
1.4 ± 0.7
Others
RCRu 5.03 ± 0.50
[3.75–6.32]
2.4 ± 0.9 3 ± 1 4.7 ± 0.4
[3.6–5.8]
3.71 ± 0.03
SRC (%) 125 ± 8
[104–146]
124 ± 41 160 ± 30 127 ± 2
[121–133]
138 ± 10
ROS/Proton leak (%) 31 ± 3
[23–39]
60 ± 40 66 ± 24 28 ± 3
[20–36]
37 ± 3
mtDNA copy number per cell 1085 ± 120
[776–1394]
849 ± 10 996 ± 80 918 ± 95
[654–1182]
1614 ± 17
mtDNA deletions 1.00 ± 0.04
[0.93–1.07]
1.1 ± 0.1 0.89 ± 0.04 1.0 ± 0.2
[0.8–1.2]
1.1 ± 0.1
Experimental details were described under Methods. ∗Activities expressed as [nmol oxygen consumed × (min × 106 cells)−1]. Data are shown as mean ± SEM for
controls and as mean ± SD for premutation carriers. Between brackets, 95% CI built with control values obtained with fibroblasts from either male children with an
average age of 8.8 ± 0.8 year (mean ± SEM) or adult females with an average age of 39.8 ± 2.5 year (mean ± SEM). Bolded values are below the 95% CI limit, except
ROS/proton leak and mtDNA copy number which are above.
by confocal microscopy. Acquired images were subsequently
analyzed to allow the quantification of mitochondrial mass,
morphological features and network integrity (Dagda et al.,
2009; Valente et al., 2017; Figure 4A). A decreased mass of
polarized mitochondria was observed in fibroblasts from twin
2 and the mother compared to their respective age- and sex-
matched NC. This was supported by the decreased mitochondrial
footprint (defined as the total mitochondrial area after being
separated from the background; Figure 4A) as well as the
reduced mitochondrial content per cell (percentage of cell area
occupied by mitochondria). A shift from the mitochondrial
tubular shape (characteristic of control cells) to smaller, more
punctuated structures was observed in twin 2, indicating either
a prevalence of mitochondrial fission over fusion. A disrupted
mitochondrial network (as judged by the mean number of
branches per network; Figure 4A) was observed in fibroblasts
from all carriers compared to controls. Surface plot analysis of
the cellular mitochondria distribution indicated a distinct, yet
modest perinuclear mitochondria distribution only in twin 2’s
cells compared to both age-matched NC and twin 1 (Figure 4B).
Taken together, the increased perikarya clustering observed in
cells from twin 2 (Figure 4B), the functional and dynamic deficits
observed in the fibroblasts of the carriers (Figure 4A), increased
uncoupling in twins (Table 4), increased mass of depolarized
mitochondria in twin 2 and mother (Figure 4A), were all findings
consistent with not only altered mitochondrial homeostasis but
also their distribution and cytoskeleton reorganization (Chen and
Chan, 2006).
Mitochondrial ROS-Dependent HIF-1a
Stabilization Underlies the PM-Induced
Bioenergetics Deficits
As increased mitochondrial ROS production is often associated
with the accumulation of defective mitochondria, we tested
for mitochondrial superoxide anion production by utilizing
MitoSOX staining. The specificity of the staining for
mitochondrial ROS was confirmed by using NC fibroblasts
which showed negligible staining in the presence of an uncoupler
(FCCP, which decreases ROS production) and an intense and
punctuated staining obtained with antimycin A (increases ROS
production at Complex III; Figure 5). A significant higher
mitochondrial superoxide anion production was observed in the
fibroblasts from the carriers (Figure 5), resulting in 2.9-, 3.5-,
and 1.7-fold of sex- and age-matched NC for twin 1, twin 2 and
mother, respectively. These data are consistent with the observed
increases in oligomycin-resistant oxygen uptake (Table 4).
As increased mitochondrial ROS production can stabilize and
prevent the degradation of HIF-1α (Bardos and Ashcroft, 2005),
thereby decreasing mitochondria proliferation, mitochondrial
mass and metabolism (Semenza, 2011), we tested the protein
expression of HIF-1α as well as that of its downstream target, the
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FIGURE 2 | Correlation of mitochondrial outcomes between lymphocytes and fibroblasts from each carrier. Outcomes evaluated in lymphocytes (averaged from
outcomes assessed at three different time points) of each twin were plotted vs. the same outcomes from fibroblasts (evaluated on 01/27/2014) (Tables 3, 4). The
same analysis was performed with the data from the mother. The linear regression (solid line) and the 95% CI (dotted lines) were built with control values. Outcomes
outside of the 95% CI were FAD-dependent oxygen uptake, CCO, CCO/CS for twin 1; NAD- and FAD-dependent oxygen uptake, CCO, mtDNA copy number and
CCO/CS for twin 2. Outcomes outside of the 95% CI evaluated with adult control values were for the mother: NAD-dependent oxygen uptake and CCO.
hypoxia up-regulated mitochondrial movement regulator protein
(HUMMR; Li et al., 2009), and several others genes involved
in mitochondrial biogenesis. Despite that all PM carriers’ cells
showed higher mitochondrial levels of ROS/proton leak (Table 4)
and mitochondrial ROS (Figure 5), the protein levels of HIF-
1α and HUMMR were significantly increased only in the twins’
cells relative to age-matched NC (Figure 6A and Supplementary
Figure 3). Twin 2’s values were 1.4-fold of his brother’s, mirroring
the higher mitochondrial ROS production (1.2-fold). Contrary
to the expectation that HIF-1α stabilization would lead to a
switch from OXPHOS to glycolysis, and as such an increase
in the [lactate]-to-[pyruvate] ratio (L/P), a higher L/P was only
observed in twin 2’s cells (L/P = 24; 95% CI = 16.3–19.6;
n = 6). This higher L/P ratio in twin 2 was accompanied
by a down-regulation of most genes involved in mitochondria
biogenesis (including PGC-1α and PGC-1β; Figure 6B). The
protein expression of the mitochondrial NAD+-dependent
sirtuin deacetylase SIRT3 [a target of PGC-1α, suppressor of
mitochondrial ROS and a factor in mitochondrial biogenesis
(Kong et al., 2010)] was higher only in the mother’s cells than
age-matched NC (Figure 6A).
DISCUSSION
Mitochondrial dysfunction has emerged as a common
mechanism underlying many neurological (Ross-Inta et al.,
2010) and neurodevelopmental disorders (Giulivi et al., 2010),
characterized by lower ATP production, increased mitochondrial
ROS, or metabolite-inhibition of critical steps within
mitochondrial pathways (Johri and Beal, 2012). MD has
been previously reported in fibroblasts from young adults and
older PM carriers with a direct correlation between severity
of MD and the occurrence of clinical symptoms (Ross-Inta
et al., 2010; Napoli et al., 2011). For the first time we hereby
report an in-depth characterization of MD in 8 years old PM
MZ twins presenting severe emotional and psychiatric deficits,
not accompanied by intellectual and/or cognitive issues. At
a molecular level both twins were characterized by a broad
size range of CGG repeats at the upper limit, accompanied by
lower FMRP levels than age-matched NC values. This outcome
could be explained by deficits in the translational efficiency, as
previously reported for other carriers, particularly when carrying
FMR1 alleles in the upper PM range (Primerano et al., 2002).
In search for a mechanism underlying the observed clinical
phenotypes, and considering the critical reliance of brain
on mitochondria-derived ATP, we characterized in detail the
status of mitochondrial function, morphology and distribution,
oxidative stress, and related signal transduction pathways in
their dermal fibroblasts and lymphocytes, both proven to be
suitable in vitro models for the study of CNS (Ross-Inta et al.,
2010; Napoli et al., 2016b). Although it could be argued that
testing for both cell types might be redundant, the collective
information is complementary based on differences in (i) germ
layer lineage (fibroblasts, as neurons, are ectodermal in origin,
whereas immune cells are derived from the mesoderm); (ii)
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FIGURE 3 | Expression of mitochondrial genes in fibroblasts from the twins and their mother. The gene expression was evaluated by qRT-PCR utilizing dual-labeled
probes. Gene expression is reported as log 2 fold-change relative to age- and sex-matched control values (n = 5 for each group) and was calculated as described in
the Materials and Methods and Supplementary Methods. Pie charts show percentages of upregulated, downregulated, or unchanged gene expression in the
twins and the mother. UPRmt, mitochondrial unfolded protein response; mitochondrial products encoded by the nuclear genome (MNEG, mitochondrial
nuclear-encoded genes) or by the mitochondrial DNA genome (MMEG, mitochondrial mtDNA-encoded genes); mtDNA, mitochondrial DNA; MICOS, mitochondrial
contact site and cristae organizing system complex (also known as MINOS or MitOS Complex).
environmental milieu (carrier’s environment in lymphocytes
vs. fibroblasts grown under optimal conditions and removed
several generations from the carrier); (iii) and proliferative status
(terminally differentiated cells vs. proliferative ones in which the
redox status of the latter is more oxidative to match the higher
ATP demands needed for rapid growth).
In the twins’ lymphocytes, the deficits in OXPHOS were
(in most cases) proportional to those of mitochondrial mass,
indicating an imbalance between mitochondria biogenesis
(including mtDNA replication) and clearance. This imbalance
was reflected as an accumulation of damaged mitochondria with
higher ROS/proton leak and lower Complex IV activity. In this
regard, it is likely that enhanced mitochondrial ROS-mediated
inhibition of the prolyl hydroxylases-dependent degradation
of HIF-1α (Bardos and Ashcroft, 2005) stabilized this factor
under normoxic conditions, ensuing in decreased mitochondria
proliferation, mass and metabolism (Semenza, 2011), more
pronounced in twin 2’s cells.
The mitochondrial abnormalities recorded in twin 2’
fibroblasts indicated a decrease in the repair mechanism of
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FIGURE 4 | Mitochondrial mass, morphology and distribution in fibroblasts from twins, their mother and relative controls. (A) (Top) Mitochondrial staining was carried
out with MitoTracker Red CMXRos (as described in the Materials and Methods) and shown in gray scale. (Middle) The outline of the mitochondrial network obtained
with the MiNA macro for Fiji is shown in red. Bottom. Parameters assessed by this plugin include mitochondrial footprint, total and average mitochondrial area,
circularity index, and network size. YC, young controls; AC, adult controls; T1, Twin 1; T2, Twin 2; M, Mother. (B) Representative plots and histogram outlines
showing mitochondrial distribution in fibroblasts from twins, their mother and respective controls. Images were obtained with the surface plot feature and analyzed
with the plot profile tools in Fiji. Histogram outlines were obtained averaging data from at least 10 images per cell line. On the x axis is the distribution of the
fluorescence intensities (FI). Values that are further from the center of the axis represent mitochondrial with less perinuclear localization.
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FIGURE 5 | Mitochondrial ROS production in fibroblasts from twins, mother and controls. Representative images of ROS levels in fibroblasts from twins, their
mother, and young (YC) and adult (AC) controls were obtained upon labeling of the cells with 5 µM MitoSOX as described in the Section “Materials and Methods.”
Fluorescence intensity (FI) was analyzed with Fiji, normalized by cell area and shown as the median with intervals. Statistical analysis was performed with the
one-way ANOVA followed by Kruskal–Wallis post hoc test for twins and respective controls and with Mann–Whitney t-test between mother and age-matched
controls. P-values are as follows: a = 0.0255, b = 0.0047, c = 0.0317. Young and adult control cells pre-treated with antimycin A and FCCP were used as positive
and negative controls respectively. Fluorescence intensities of cells exposed to antimycin A and FCCP normalized by cell area are shown in the inset.
A Mann–Whitney t-test was performed between the two groups. ∗∗∗∗p < 0.0001.
FIGURE 6 | Mitochondrial biogenesis and levels of HIF-1α and SIRT3 in fibroblasts from twins, their mother and controls. (A) Representative Western blot images
and densitometry of HIF-1α levels in fibroblasts from controls, twins and their mother. Data are shown as mean ± SEM for controls. Mean ± SD was used for twins
and their mother’s values as an index of intra-experimental variability. Reported are also the limits of the 95% CI obtained with age- and sex-matched controls
(between brackets). Underlined values are higher than the upper limit of the 95% CI. (B) Expression of genes (by qRT-PCR utilizing dual-labeled probes) involved in
mitochondrial biogenesis.
damaged mitochondrial proteins and/or clearance of damaged
mitochondria. These events were accompanied by lower PGC-1α
and PGC-1β gene expression, and HIF-1α stabilization with a
defective UPRmt activation. The bioenergetics’ defects observed
in twin 2’s fibroblasts were considerable, for some of them
crossed the threshold for energy deficiency, consistent with the
repression of both transcriptional PGC co-activators and the lack
of compensation by the increased glycolysis. This is supported
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by a ratio of mitochondrial-to-glycolysis ATP of 0.6, significantly
lower than that of NC (1.0), and near the energy threshold
for brain OXPHOS (≤50% of Complex I activity (Rossignol
et al., 2003)), segregating with the worse phenotype. While the
lower LRPPRC gene expression in twin 2’ cells should have
triggered basal autophagy (Zhang et al., 2017) and mitophagy
(Zou et al., 2013), the accumulation of damaged/dysfunctional
mitochondria (i.e., increased depolarized mass) could be
explained by considering that LRPPRC activity requires its
association with cytoskeleton elements participating in vesicular
distribution of both membrane and nuclear organelles (Xie et al.,
2011), processes involving the formation of vesicles and their
trafficking through the cytoskeleton network (such as mitophagy
and autophagy) which could be affected or halted when FMRP
is deficient. The lower gene expression of LRPPRC might
also contribute to the significant OXPHOS deficits and lower
Complex IV activity, considering that LRPPRC is a component
of the PGC-1α complex linked to cellular energy homeostasis
(Zhang et al., 2017) and that pathogenic LRPPRC mutations
result in impaired Complex IV assembly and activity (Xu et al.,
2004).
The bioenergetics of fibroblasts from twin 1 showed an
intermediate situation between his brother and mother. The
control levels of both PGC-1β and SIRT3 seemed to partly
counteract the downstream effects triggered by the mitochondrial
ROS-dependent stabilization of HIF-1α resulting in no increases
in the glycolytic flux (control L/P ratio) with no significant
accumulation of damaged mitochondria, but still milder
OXPHOS deficits.
In the case of the mother, fewer outcomes seemed affected,
likely via activation of some compensatory mechanisms,
thereby preventing profound energy deficits. The imbalanced
stoichiometry between components of OXPHOS complexes
triggered the mitochondrial-to-nuclear signaling to increase
UPRmt response to maintain protein quality and mitochondrial
function (Pellegrino et al., 2013). This is supported by the
relatively milder mitochondrial ROS levels in the mother’s cells
(not enough to activate HIF-1α) and the higher content of
more depolarized mitochondria (which could be interpreted in
the context of all results as an increase in OXPHOS). Notably,
the higher expression of PGC-1β in the mother’s cells (but not
that of PGC-1α) may suggest the conservation of mitochondrial
fatty acid β-oxidation (Kamei et al., 2003), process that fuels
less pro-inflammatory stress responses (Pellegrino et al., 2014).
The increased gene expression of LRPPRC, higher mtDNA copy
number, normal L/P, and up-regulation of SIRT3, PGC-1β, and
UPRmt seem enough to sustain an adequate OXPHOS activity in
the mother’s cells but not to preserve the mitochondrial network,
process that relays on the integration with cytoskeletal proteins
(Xie et al., 2011).
A relevant question is which biochemical outcomes associate
with any of the clinical diagnoses received by the twins and
their mother. One possible scenario is that mitochondrial deficits
shared by both twins may underlie the pathogenic mechanisms
leading to the neurological symptoms present in both children
(depression, mood instability, ADHD), whereas others (e.g.,
a more severe OXPHOS deficit, higher mitochondrial ROS
production, repression of PGC-1α/β) may associate with the
bipolar disorder, maniac behavior, and chronic fatigue diagnosed
solely in twin 2. Hence, these differences may be rooted
on additional environmental stress imposed by the chronic
inflammation triggered by Lyme disease in twin 2, given that
the degree of the pro-inflammatory immune responses is fueled
by the balance between glucose vs. fatty acid oxidation (Arnoult
et al., 2011). Similarly, the lower lymphocytic citrate synthase
activity observed in both parents compared to age-matched NC,
may point to shared environmental stress factors, whereas the
outcomes found deficient in the mother only (vs. her spouse)
may be attributed to her carrier status. Although a MD was
observed in the mother’s cells at a lower extent than the twins,
her unfavorable XAR in both lymphocytes and fibroblasts and
the high FMR1 mRNA levels in peripheral blood could play a
role in her FXPOI condition, as it has been widely reported in
the PM (Sherman, 2000). A key implication of these findings
is that the different degree of severity in the twins vs. their
mother may differ not only because of their contrasting genetic
background (heterozygous with 78 CGG vs. hemizygous with a
series of alleles spanning the upper range of the PM range), but
also because of their sex-steroid environment, particularly the
beneficial effects of estrogen on mitochondrial biogenesis and
quality control factors (Hara et al., 2014).
Given the role of mitochondria in providing ATP to
aerobic tissues such as brain, as well as their involvement
in neurotransmitter metabolism (Laughlin et al., 1998),
it is tempting to propose that the mitochondrial defects
identified in this study are either causals or contributors of
the emotional/developmental problems in a PM background,
exacerbated by other factors (Lyme disease, sex hormones, XAR).
Although other contributing factors cannot be ruled out, the
observed changes in the twins’ cells may originally stem from a
FMRP-dependent cellular dysregulation (not necessarily related
to FMR1 gene expression). FMRP is a polyribosome-associated
neuronal RNA-binding protein, and relatively lower protein
levels might ensue in cellular stress with the loss of translational
brakes on the synthesis of critical proteins and factors required to
sustain synaptic (e.g., synaptic long-term potentiation, glutamate
receptor signaling, CREB signaling in neurons) and other
intracellular signaling pathways (Darnell et al., 2011), including
those possibly involved in bioenergetics as well as trafficking. Our
study identified mitochondrial ROS- HIF-1α crosstalk as one
of the central pathways in the MD, suggesting the therapeutic
potential of targeting HIF-1α by small-molecule inhibitors or
modulating mitochondrial ROS production.
Study Limitations
This case report includes a detailed clinical and molecular
description of two MZ twins showing remarkable inter-
and intra-tissue somatic mosaicism with relatively long CGG
repeats and no cognitive/intellectual issues but profound
emotional/behavioral ones. Therefore, the conclusions should
not be extended to the entire PM pediatric population.
Furthermore, at the time of the assessments both twins were
receiving several medications for the management of behavioral
traits. Although none of these medications appear to impact
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directly or significantly mitochondrial function, due to the few
and somewhat contradictory reports available [methylphenidate
(Fagundes et al., 2010), sertraline (Chen et al., 2014), and
aripiprazole (Ota et al., 2012)], an effect of these drugs on the
lymphocytic (but not fibroblasts) outcomes tested in this study
cannot be entirely ruled out. If indeed these medications had
a detrimental effect on mitochondrial function, then cautionary
advice should be exercised when prescribing them to subjects
with suspected mitochondrial disorders.
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